426 related articles for article (PubMed ID: 12859586)
1. Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns.
Crown WH; Olufade A; Smith MW; Nathan R
Value Health; 2003; 6(4):448-56. PubMed ID: 12859586
[TBL] [Abstract][Full Text] [Related]
2. Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis.
Lang K; Allen-Ramey F; Huang H; Rock M; Kaufman E; Dykewicz MS
Allergy Asthma Proc; 2016 Sep; 37(5):103-11. PubMed ID: 27657517
[TBL] [Abstract][Full Text] [Related]
3. Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment.
Hay J; Jhaveri M; Tangirala M; Kaliner M
Allergy Asthma Proc; 2009; 30(6):634-42. PubMed ID: 20031009
[TBL] [Abstract][Full Text] [Related]
4. [Allergic rhinitis--an epidemiological, economical and social problem of the XXI century].
Rutkowski R; Kosztyła-Hojna B; Rutkowska J
Pneumonol Alergol Pol; 2008; 76(5):348-52. PubMed ID: 19003765
[TBL] [Abstract][Full Text] [Related]
5. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
Lee J; Cummins G; Okamoto L
Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
[TBL] [Abstract][Full Text] [Related]
6. Cost and utilization impacts of oral antihistamines in the California Medi-Cal program.
Hay JW; Leahy M
Value Health; 2005; 8(4):506-16. PubMed ID: 16091028
[TBL] [Abstract][Full Text] [Related]
7. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
Liao E; Leahy M; Cummins G
Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261
[TBL] [Abstract][Full Text] [Related]
8. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
Sullivan PW; Follin SL; Nichol MB
Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929
[TBL] [Abstract][Full Text] [Related]
9. The cost of productivity losses associated with allergic rhinitis.
Crystal-Peters J; Crown WH; Goetzel RZ; Schutt DC
Am J Manag Care; 2000 Mar; 6(3):373-8. PubMed ID: 10977437
[TBL] [Abstract][Full Text] [Related]
10. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs.
Hankin CS; Cox L; Lang D; Levin A; Gross G; Eavy G; Meltzer E; Burgoyne D; Bronstone A; Wang Z
J Allergy Clin Immunol; 2008 Jan; 121(1):227-32. PubMed ID: 18206509
[TBL] [Abstract][Full Text] [Related]
11. Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis.
Long AA
Clin Ther; 2007 Feb; 29(2):342-51. PubMed ID: 17472826
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
[TBL] [Abstract][Full Text] [Related]
13. Economic outcomes of a targeted intervention program: the costs of treating allergic rhinitis patients.
Santos R; Cifaldi M; Gregory C; Seitz P
Am J Manag Care; 1999 Apr; 5(4 Suppl):S225-34. PubMed ID: 10387543
[TBL] [Abstract][Full Text] [Related]
14. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey.
Law AW; Reed SD; Sundy JS; Schulman KA
J Allergy Clin Immunol; 2003 Feb; 111(2):296-300. PubMed ID: 12589348
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and cost comparison of three therapeutic approaches to allergic rhinitis.
Fairchild CJ; Durden E; Cao Z; Smale P
Am J Rhinol Allergy; 2011; 25(4):257-62. PubMed ID: 21639996
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of allergic rhinitis in Korea.
Kim SY; Yoon SJ; Jo MW; Kim EJ; Kim HJ; Oh IH
Am J Rhinol Allergy; 2010; 24(5):e110-3. PubMed ID: 21244726
[TBL] [Abstract][Full Text] [Related]
17. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of allergic rhinitis].
Tas E; Bircher AJ
Ther Umsch; 2001 May; 58(5):309-14. PubMed ID: 11407233
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.
Dal Negro R; Piskorz P; Vives R; Guilera M; Sazonov Kocevar V; Badia X
Pharmacoeconomics; 2007; 25(8):665-76. PubMed ID: 17640108
[TBL] [Abstract][Full Text] [Related]
20. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class.
Benninger M; Farrar JR; Blaiss M; Chipps B; Ferguson B; Krouse J; Marple B; Storms W; Kaliner M
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):13-29. PubMed ID: 20143641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
